Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
An in vitro screening method by NMR spectroscopy of potential therapeutic compounds for Congenital Central Hypoventilation Syndrome (CCHS). The method is based in the identification of active agents that inhibit secondary structure changes in PHOX2B transcription factor.
An in vitro fluorescent method for early detection of  Amyotrophic Lateral Sclerosis (ALS) and other TDP-43 related proteinopathies, such as Fronto Temporal Lobar Degeneration (FTLD), based on detection of pathological aggregates of TDP-43 present in cerebrospinal fluid.
Early and accurate diagnosis and follow up of diseases related to cystine accumulation, such as cystinosis and cystinuria, based on a molecular network producing a signal measurable by fluorescence when certain substances bind to cysteine or cystine, allowing abnormal levels of cystine to be detected.

Social Media